PROSPECTIVELY RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 STUDY TO DETERMINE THE EFFECT OF DENOSUMAB ON BREAST CANCER PREVENTION IN BRCA1 MUTATION CARRIERS
$5,232,648FY2019Defense Health AgencyDOD
Verein Zur Praevention Und Therapie Boesartiger Erkrankungen, Austrian Breast And Colorectal Cancer Study Group